Navire Pharma is developing SHP2 inhibitors as effective additions to the therapeutic arsenal for difficult-to-treat and rare cancers.

Navire Pharma Inc.
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://navirepharma.com
Founded2017
Disease Focus
Development Stage
STOCK CODENon Listed
Address421 Kipling Street,CA 94301Palo AltoUnited States
421 Kipling Street,CA 94301
Palo Alto
United States
Contact Number+1 650-391-9740
+1 650-391-9740
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/navire-pharma” connections=”true” suffix=””]